1. Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis;Shahani;The Journal of Clinical Endocrinology and Metabolism,2008
2. Bone and Metabolic Health in Patients with Prostate Cancer Receiving Androgen Deprivation Therapy- Management Guidelines on behalf of the Endocrine Society of Australia, the Australian and New Zealand Bone and Mineral Society, and the Urological Society of Australia and New Zealand;Grossmann;Medical Journal of Australia,2010
3. Structural decay of bone microarchitecture in men with prostate cancer treated with androgen deprivation therapy;Hamilton;The Journal of Clinical Endocrinology and Metabolism,2010
4. Androgen deprivation therapy for prostate cancer: new concepts and concerns;Smith;Current Opinion in Endocrinology, Diabetes and Obesity,2007
5. Low testosterone levels are common and associated with insulin resistance in men with diabetes;Grossmann;The Journal of Clinical Endocrinology and Metabolism,2008